Remove us-companies
article thumbnail

US Public Company Board Diversity in 2023: How Corporate Director Diversity Can Contribute to Board Effectiveness

Harvard Corporate Governance

Normal 0 false false false false EN-US X-NONE X-NONE This report documents corporate governance trends and developments at US publicly traded companies—including information on board composition and diversity, the profile and skill sets of directors, and policies on their election, removal, and retirement.

Equity 317
article thumbnail

Director Compensation: Increases Are Back Among the Largest US Companies

Harvard Corporate Governance

Each year CAP analyzes non-employee director compensation programs among the 100 largest US public companies. These companies are trendsetters and can provide early insights into evolving pay practices across the broader public company marketplace. Key Takeaways Median total board compensation increased 2.6%

Equity 130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

FTSE 250 company Tyman snapped up by US rival in £788m deal

The Guardian M&A

Building products supplier is latest British-listed company to be bought by a foreign buyer Business live – latest updates The London Stock Exchange’s mid-sized FTSE 250 index is due to lose a 186-year-old manufacturing company to a US takeover – the latest in a series of purchases by foreign buyers in recent years.

article thumbnail

US Publicly-Traded Buyers’ Interest In Acquiring Middle-Market Companies Increases

Benchmark Report

Thanks to the new 1% tax now being levied on any publicly traded US companies that buy back their shares, these larger, cash-rich companies have been given a strong incentive to seek acquisition targets.

article thumbnail

Blank-cheque company aims to buy failed US banks

Financial Times M&A

Porticoes Capital bets on further turmoil with approval to take over collapsed lenders from FDIC

Banking 100
article thumbnail

Cross-Border Reverse Mergers: A US IPO Alternative for Foreign Companies

John Jenkins

This Cooley blog discusses how reverse mergers with existing US public companies are becoming an increasingly popular way for foreign companies to access the US capital markets.

article thumbnail

AstraZeneca buys US vaccine company in $1.1bn deal

The Guardian M&A

Britain’s biggest drugmaker acquires Seattle-based firm Icosavax, expanding vaccine and immune therapy business AstraZeneca is buying its first vaccine company in a $1.1bn deal that will expand the vaccine and immune therapy business it set up during the Covid-19 pandemic.

73